CBIO Q2 2017 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$327M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$69,574

Operating Income

-$8M

Net Income

-$8M

EPS (Diluted)

$-0.30

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$991,108

Balance Sheet

Total Assets

$122M

Total Liabilities

$6M

Stockholders' Equity

$115M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$69,574	$0	—
Operating Income	-$8M	-$8M	-1.9%
Net Income	-$8M	-$8M	-0.9%